

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 9.23111871 |
| 2 | lipoprotein transport (GO:0042953) | 7.58071398 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 7.47541817 |
| 4 | NADH metabolic process (GO:0006734) | 7.11034701 |
| 5 | regulation of bile acid biosynthetic process (GO:0070857) | 6.87743787 |
| 6 | intestinal absorption (GO:0050892) | 6.78407755 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.70810328 |
| 8 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.53450818 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.80204867 |
| 10 | hormone catabolic process (GO:0042447) | 5.68113878 |
| 11 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.61524690 |
| 12 | endocrine process (GO:0050886) | 5.61524690 |
| 13 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.61524690 |
| 14 | fructose metabolic process (GO:0006000) | 5.54520939 |
| 15 | regulation of cellular extravasation (GO:0002691) | 5.41808230 |
| 16 | virion attachment to host cell (GO:0019062) | 5.27917534 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 5.27917534 |
| 18 | regulation of systemic arterial blood pressure (GO:0003073) | 5.07578057 |
| 19 | drug metabolic process (GO:0017144) | 4.84473806 |
| 20 | peptide hormone processing (GO:0016486) | 4.78041844 |
| 21 | cellular glucuronidation (GO:0052695) | 4.73487178 |
| 22 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.65698048 |
| 23 | uronic acid metabolic process (GO:0006063) | 4.65624976 |
| 24 | glucuronate metabolic process (GO:0019585) | 4.65624976 |
| 25 | diacylglycerol metabolic process (GO:0046339) | 4.64631668 |
| 26 | urea cycle (GO:0000050) | 4.64366692 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.62919565 |
| 28 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.59162255 |
| 29 | regulation of cGMP biosynthetic process (GO:0030826) | 4.57071514 |
| 30 | peptide catabolic process (GO:0043171) | 4.50204081 |
| 31 | adhesion of symbiont to host (GO:0044406) | 4.47832826 |
| 32 | bile acid and bile salt transport (GO:0015721) | 4.44831096 |
| 33 | urea metabolic process (GO:0019627) | 4.42689623 |
| 34 | glycolipid catabolic process (GO:0019377) | 4.33029339 |
| 35 | glycosphingolipid catabolic process (GO:0046479) | 4.31498216 |
| 36 | vitamin A metabolic process (GO:0006776) | 4.28473485 |
| 37 | antibacterial humoral response (GO:0019731) | 4.27861366 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 4.25519373 |
| 39 | antimicrobial humoral response (GO:0019730) | 4.12739883 |
| 40 | renal system process involved in regulation of blood volume (GO:0001977) | 4.11506643 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 4.08215919 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.06729557 |
| 43 | drinking behavior (GO:0042756) | 4.04287957 |
| 44 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.00568582 |
| 45 | flavonoid metabolic process (GO:0009812) | 3.95395263 |
| 46 | * digestion (GO:0007586) | 3.85408061 |
| 47 | cellular response to nitric oxide (GO:0071732) | 3.84662029 |
| 48 | regulation of cGMP metabolic process (GO:0030823) | 3.79370296 |
| 49 | alkaloid metabolic process (GO:0009820) | 3.76303254 |
| 50 | lipoprotein metabolic process (GO:0042157) | 3.74757649 |
| 51 | vitamin transmembrane transport (GO:0035461) | 3.73290686 |
| 52 | homocysteine metabolic process (GO:0050667) | 3.72739756 |
| 53 | protein-lipid complex assembly (GO:0065005) | 3.72453150 |
| 54 | fat-soluble vitamin metabolic process (GO:0006775) | 3.67346124 |
| 55 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.65837833 |
| 56 | positive regulation of pseudopodium assembly (GO:0031274) | 3.64816618 |
| 57 | drug catabolic process (GO:0042737) | 3.58674197 |
| 58 | vitamin transport (GO:0051180) | 3.58570770 |
| 59 | midgut development (GO:0007494) | 3.56793979 |
| 60 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.55579357 |
| 61 | ceramide catabolic process (GO:0046514) | 3.47984003 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42137504 |
| 63 | response to nitric oxide (GO:0071731) | 3.42059584 |
| 64 | mRNA modification (GO:0016556) | 3.41036124 |
| 65 | exogenous drug catabolic process (GO:0042738) | 3.38729571 |
| 66 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.38672805 |
| 67 | arginine metabolic process (GO:0006525) | 3.37552191 |
| 68 | glycosylceramide metabolic process (GO:0006677) | 3.37246022 |
| 69 | digestive system process (GO:0022600) | 3.35620465 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35291273 |
| 71 | cGMP biosynthetic process (GO:0006182) | 3.34943004 |
| 72 | bile acid metabolic process (GO:0008206) | 3.33724231 |
| 73 | cellular response to reactive nitrogen species (GO:1902170) | 3.33176875 |
| 74 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.30405822 |
| 75 | regulation of cholesterol homeostasis (GO:2000188) | 3.28518092 |
| 76 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.28237380 |
| 77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.26617279 |
| 78 | regulation of pseudopodium assembly (GO:0031272) | 3.26431313 |
| 79 | cGMP-mediated signaling (GO:0019934) | 3.25116142 |
| 80 | glomerulus development (GO:0032835) | 3.23988890 |
| 81 | phospholipid efflux (GO:0033700) | 3.22765090 |
| 82 | sexual reproduction (GO:0019953) | 3.22685242 |
| 83 | sphingolipid catabolic process (GO:0030149) | 3.22267990 |
| 84 | citrulline biosynthetic process (GO:0019240) | 3.20856998 |
| 85 | drug transport (GO:0015893) | 3.17875025 |
| 86 | vitamin biosynthetic process (GO:0009110) | 3.17481709 |
| 87 | actin filament depolymerization (GO:0030042) | 3.16503217 |
| 88 | glycerol metabolic process (GO:0006071) | 3.14415723 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13557581 |
| 90 | sphingomyelin metabolic process (GO:0006684) | 3.13292375 |
| 91 | transcytosis (GO:0045056) | 3.13012446 |
| 92 | sulfate transmembrane transport (GO:1902358) | 3.11990011 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 3.10234353 |
| 94 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.08989812 |
| 95 | cobalamin metabolic process (GO:0009235) | 3.07942675 |
| 96 | membrane lipid catabolic process (GO:0046466) | 3.07829154 |
| 97 | vitamin D metabolic process (GO:0042359) | 3.07465460 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.06676698 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.06676698 |
| 100 | angiotensin maturation (GO:0002003) | 12.0025869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.42732977 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.25659580 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.83465401 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.17963326 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.13311776 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.03818811 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.02733050 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55317055 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53950916 |
| 10 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.53479392 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46577770 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.46262763 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45714827 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.40930856 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.27306872 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.26077339 |
| 17 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.25047126 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24089039 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23281228 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.08411749 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94040154 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.92131823 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88322764 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80898840 |
| 25 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80561637 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.78583808 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.68353343 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.63296077 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60516810 |
| 30 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.57967712 |
| 31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.55707205 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54209853 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52782763 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44737388 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42947710 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34445512 |
| 37 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.33137442 |
| 38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32965843 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29639892 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28679282 |
| 41 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27061447 |
| 42 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.22825490 |
| 43 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21842746 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17955409 |
| 45 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17950230 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16548930 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15015710 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10408251 |
| 49 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10142499 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09726145 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08519719 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08342088 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06009124 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05111796 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04789003 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01149026 |
| 57 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01085432 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00657534 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98155554 |
| 60 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98005356 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95972050 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95158600 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94109879 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93457529 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93424038 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93357749 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93173239 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91248055 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90354925 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90343102 |
| 71 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.89917286 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89390422 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89119333 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88546170 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88502436 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88340543 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86272073 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86163877 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85802168 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85425699 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84909800 |
| 82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83544709 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83489158 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80511821 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80280354 |
| 86 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79960439 |
| 87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.79464169 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79369368 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78654101 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78353648 |
| 91 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.78121333 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77844861 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.77683650 |
| 94 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77300851 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76923039 |
| 96 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76575437 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75595657 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75352409 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75064054 |
| 100 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74404602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.21754594 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.81832923 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.80131557 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.70548201 |
| 5 | MP0004147_increased_porphyrin_level | 3.76327117 |
| 6 | MP0005365_abnormal_bile_salt | 3.70621824 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.66140266 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.64417719 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.50670658 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.48783363 |
| 11 | MP0009840_abnormal_foam_cell | 3.18781774 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.78470846 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.70683006 |
| 14 | MP0005409_darkened_coat_color | 2.27657927 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.07653096 |
| 16 | MP0003866_abnormal_defecation | 2.06058353 |
| 17 | MP0001664_abnormal_digestion | 2.01281663 |
| 18 | MP0003868_abnormal_feces_composition | 1.86041599 |
| 19 | MP0005332_abnormal_amino_acid | 1.84424753 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.79833795 |
| 21 | MP0000490_abnormal_crypts_of | 1.74507478 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.65618544 |
| 23 | MP0000538_abnormal_urinary_bladder | 1.63891655 |
| 24 | MP0003252_abnormal_bile_duct | 1.60696077 |
| 25 | MP0001764_abnormal_homeostasis | 1.56733121 |
| 26 | MP0005166_decreased_susceptibility_to | 1.55932053 |
| 27 | MP0000477_abnormal_intestine_morphology | 1.44023740 |
| 28 | MP0001188_hyperpigmentation | 1.43160007 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.43147840 |
| 30 | MP0005670_abnormal_white_adipose | 1.42850193 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.40471770 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.39150820 |
| 33 | MP0004858_abnormal_nervous_system | 1.31143060 |
| 34 | MP0001873_stomach_inflammation | 1.30968079 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.28565332 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.26740635 |
| 37 | MP0002136_abnormal_kidney_physiology | 1.19313957 |
| 38 | MP0003718_maternal_effect | 1.18720208 |
| 39 | MP0002822_catalepsy | 1.18109560 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.17154430 |
| 41 | MP0001663_abnormal_digestive_system | 1.15699382 |
| 42 | MP0004270_analgesia | 1.13826577 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.13037491 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.11398899 |
| 45 | MP0000462_abnormal_digestive_system | 1.10507967 |
| 46 | MP0003879_abnormal_hair_cell | 1.07417517 |
| 47 | MP0005448_abnormal_energy_balance | 1.03220717 |
| 48 | MP0005535_abnormal_body_temperature | 0.98135790 |
| 49 | MP0004043_abnormal_pH_regulation | 0.97790776 |
| 50 | MP0005381_digestive/alimentary_phenotyp | 0.96780540 |
| 51 | MP0000609_abnormal_liver_physiology | 0.96482450 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93291675 |
| 53 | MP0002396_abnormal_hematopoietic_system | 0.92859624 |
| 54 | MP0002971_abnormal_brown_adipose | 0.90086323 |
| 55 | MP0001756_abnormal_urination | 0.86834069 |
| 56 | MP0001845_abnormal_inflammatory_respons | 0.86755700 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 0.84816977 |
| 58 | MP0000230_abnormal_systemic_arterial | 0.82988531 |
| 59 | MP0000537_abnormal_urethra_morphology | 0.81084078 |
| 60 | MP0003300_gastrointestinal_ulcer | 0.80622831 |
| 61 | MP0005451_abnormal_body_composition | 0.80219025 |
| 62 | MP0002098_abnormal_vibrissa_morphology | 0.77847559 |
| 63 | MP0009115_abnormal_fat_cell | 0.77793446 |
| 64 | MP0002166_altered_tumor_susceptibility | 0.76623843 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.73358753 |
| 66 | MP0008469_abnormal_protein_level | 0.72718971 |
| 67 | MP0009785_altered_susceptibility_to | 0.72069750 |
| 68 | MP0002796_impaired_skin_barrier | 0.70990167 |
| 69 | MP0009642_abnormal_blood_homeostasis | 0.66889122 |
| 70 | MP0003724_increased_susceptibility_to | 0.65971977 |
| 71 | MP0001835_abnormal_antigen_presentation | 0.65649555 |
| 72 | MP0001485_abnormal_pinna_reflex | 0.64745106 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.60788736 |
| 74 | MP0000604_amyloidosis | 0.58920482 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.58785684 |
| 76 | MP0009764_decreased_sensitivity_to | 0.58413322 |
| 77 | MP0005025_abnormal_response_to | 0.58200065 |
| 78 | MP0000249_abnormal_blood_vessel | 0.57921593 |
| 79 | MP0006082_CNS_inflammation | 0.56044111 |
| 80 | MP0002896_abnormal_bone_mineralization | 0.55618755 |
| 81 | MP0006138_congestive_heart_failure | 0.55276594 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.54602327 |
| 83 | MP0005501_abnormal_skin_physiology | 0.53677485 |
| 84 | MP0003329_amyloid_beta_deposits | 0.53141074 |
| 85 | MP0004947_skin_inflammation | 0.52410192 |
| 86 | MP0008872_abnormal_physiological_respon | 0.51417108 |
| 87 | MP0003303_peritoneal_inflammation | 0.51089959 |
| 88 | MP0001790_abnormal_immune_system | 0.50689144 |
| 89 | MP0005387_immune_system_phenotype | 0.50689144 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.50362556 |
| 91 | MP0003436_decreased_susceptibility_to | 0.49681795 |
| 92 | MP0005334_abnormal_fat_pad | 0.49234631 |
| 93 | MP0001881_abnormal_mammary_gland | 0.48784101 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.48697637 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 0.48477522 |
| 96 | MP0002006_tumorigenesis | 0.48355146 |
| 97 | MP0003953_abnormal_hormone_level | 0.46012293 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.45477066 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.44965114 |
| 100 | MP0002009_preneoplasia | 0.40474113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of proline metabolism (HP:0010907) | 7.48850083 |
| 2 | Hydroxyprolinuria (HP:0003080) | 7.48850083 |
| 3 | Malnutrition (HP:0004395) | 7.28767912 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.96713814 |
| 5 | Chronic diarrhea (HP:0002028) | 5.83273271 |
| 6 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.47443350 |
| 7 | Acanthocytosis (HP:0001927) | 5.16993622 |
| 8 | Abnormality of vitamin B metabolism (HP:0004340) | 5.10981599 |
| 9 | Ileus (HP:0002595) | 5.08266994 |
| 10 | Fat malabsorption (HP:0002630) | 4.93926844 |
| 11 | Widely patent fontanelles and sutures (HP:0004492) | 4.86389658 |
| 12 | Confusion (HP:0001289) | 4.50286520 |
| 13 | Pigmentary retinal degeneration (HP:0001146) | 4.12174056 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 4.03756991 |
| 15 | Hyperglycinuria (HP:0003108) | 3.97521595 |
| 16 | Thin bony cortex (HP:0002753) | 3.77246637 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.76919924 |
| 18 | Nausea (HP:0002018) | 3.68706842 |
| 19 | Wide cranial sutures (HP:0010537) | 3.68622885 |
| 20 | Abnormality of urine glucose concentration (HP:0011016) | 3.68124019 |
| 21 | Glycosuria (HP:0003076) | 3.68124019 |
| 22 | Proximal tubulopathy (HP:0000114) | 3.37339695 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.31889338 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.31889338 |
| 25 | Abdominal distention (HP:0003270) | 3.22063930 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.17833286 |
| 27 | Potter facies (HP:0002009) | 3.15241082 |
| 28 | Facial shape deformation (HP:0011334) | 3.15241082 |
| 29 | Decreased circulating renin level (HP:0003351) | 3.15104913 |
| 30 | Steatorrhea (HP:0002570) | 3.03195590 |
| 31 | Xanthomatosis (HP:0000991) | 3.02253840 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 3.02223926 |
| 33 | Hyperuricemia (HP:0002149) | 2.97436587 |
| 34 | Increased purine levels (HP:0004368) | 2.97436587 |
| 35 | Alkalosis (HP:0001948) | 2.95504643 |
| 36 | Metabolic alkalosis (HP:0200114) | 2.94731894 |
| 37 | Megaloblastic anemia (HP:0001889) | 2.94406081 |
| 38 | Hypophosphatemia (HP:0002148) | 2.92924792 |
| 39 | Posterior subcapsular cataract (HP:0007787) | 2.91155694 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86901803 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.85914844 |
| 42 | * Nephrolithiasis (HP:0000787) | 2.80252226 |
| 43 | Enlarged epiphyses (HP:0010580) | 2.77036745 |
| 44 | Hyperparathyroidism (HP:0000843) | 2.72272499 |
| 45 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.69696501 |
| 46 | Villous atrophy (HP:0011473) | 2.69696501 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.65191175 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.64799444 |
| 49 | Hyperammonemia (HP:0001987) | 2.64583817 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.64110610 |
| 51 | Abnormal urine phosphate concentration (HP:0012599) | 2.57636387 |
| 52 | Delayed epiphyseal ossification (HP:0002663) | 2.57293173 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.50374196 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49826440 |
| 55 | Abnormal glucose tolerance (HP:0001952) | 2.42421839 |
| 56 | Hypotension (HP:0002615) | 2.42321498 |
| 57 | Abnormality of the costochondral junction (HP:0000919) | 2.38872016 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.38664971 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.36444295 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33719533 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.29914935 |
| 62 | Epidermoid cyst (HP:0200040) | 2.23493487 |
| 63 | Poikilocytosis (HP:0004447) | 2.22775407 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15929590 |
| 65 | Subcapsular cataract (HP:0000523) | 2.15621615 |
| 66 | Hyperphosphatemia (HP:0002905) | 2.14169932 |
| 67 | Metabolic acidosis (HP:0001942) | 2.12656229 |
| 68 | Protuberant abdomen (HP:0001538) | 2.11433359 |
| 69 | Gout (HP:0001997) | 2.10600449 |
| 70 | Gingivitis (HP:0000230) | 2.10594468 |
| 71 | Renal tubular acidosis (HP:0001947) | 2.05689788 |
| 72 | Gastrointestinal dysmotility (HP:0002579) | 2.02470856 |
| 73 | Cerebral palsy (HP:0100021) | 2.00642035 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.8040249 |
| 75 | Pancreatitis (HP:0001733) | 1.97096083 |
| 76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96497054 |
| 77 | Abnormality of magnesium homeostasis (HP:0004921) | 1.93384361 |
| 78 | Flat acetabular roof (HP:0003180) | 1.89704212 |
| 79 | Multiple lipomas (HP:0001012) | 1.85135952 |
| 80 | Glomerulosclerosis (HP:0000096) | 1.84173979 |
| 81 | Irritability (HP:0000737) | 1.84133818 |
| 82 | Glomerulonephritis (HP:0000099) | 1.81625545 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.79151094 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 1.79151094 |
| 85 | Abnormal biliary tract morphology (HP:0012440) | 1.78121453 |
| 86 | Growth hormone excess (HP:0000845) | 1.77702780 |
| 87 | Renal tubular dysfunction (HP:0000124) | 1.76590255 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75878067 |
| 89 | Abnormality of complement system (HP:0005339) | 1.73502023 |
| 90 | Hypocalcemia (HP:0002901) | 1.73324582 |
| 91 | Symptomatic seizures (HP:0011145) | 1.71725349 |
| 92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71408871 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71006768 |
| 94 | Nephritis (HP:0000123) | 1.70991083 |
| 95 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70327287 |
| 96 | Dehydration (HP:0001944) | 1.68987351 |
| 97 | Metaphyseal irregularity (HP:0003025) | 1.67990749 |
| 98 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.65908817 |
| 99 | Peripheral demyelination (HP:0011096) | 1.64870686 |
| 100 | Complement deficiency (HP:0004431) | 1.64593501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.43946288 |
| 2 | MST1R | 4.40554520 |
| 3 | ERN1 | 4.40288963 |
| 4 | MAP3K10 | 3.59918106 |
| 5 | PRKG2 | 3.58908376 |
| 6 | RIPK1 | 3.53103915 |
| 7 | STK39 | 2.64371248 |
| 8 | EPHA2 | 2.54989167 |
| 9 | OXSR1 | 2.09878082 |
| 10 | FGFR4 | 1.93903002 |
| 11 | TESK2 | 1.84125227 |
| 12 | EPHA3 | 1.74515069 |
| 13 | MAP3K2 | 1.69177963 |
| 14 | MET | 1.67092581 |
| 15 | TYK2 | 1.64276060 |
| 16 | PTK6 | 1.57993504 |
| 17 | TNIK | 1.55469944 |
| 18 | EPHB2 | 1.51027928 |
| 19 | PDK2 | 1.49747291 |
| 20 | AKT3 | 1.49383919 |
| 21 | MAP3K12 | 1.46719814 |
| 22 | DDR2 | 1.37817330 |
| 23 | EPHB1 | 1.33723124 |
| 24 | GRK6 | 1.30176612 |
| 25 | MST4 | 1.25831314 |
| 26 | PRPF4B | 1.20982724 |
| 27 | MAP4K1 | 1.20336502 |
| 28 | FGFR3 | 1.16893552 |
| 29 | STK24 | 1.13867681 |
| 30 | MATK | 1.12072729 |
| 31 | RIPK4 | 1.10182272 |
| 32 | MYLK | 1.09248558 |
| 33 | MAP3K1 | 1.06779509 |
| 34 | NLK | 1.04023011 |
| 35 | EPHA4 | 1.00290939 |
| 36 | PIK3CA | 0.98107474 |
| 37 | MAP2K2 | 0.96433532 |
| 38 | LMTK2 | 0.93558627 |
| 39 | ERBB2 | 0.91490107 |
| 40 | CDC42BPA | 0.82602283 |
| 41 | PDPK1 | 0.80180800 |
| 42 | CASK | 0.78862571 |
| 43 | PIM1 | 0.75320515 |
| 44 | BMPR2 | 0.74661660 |
| 45 | FER | 0.73324862 |
| 46 | TESK1 | 0.72734418 |
| 47 | PRKAA2 | 0.72435314 |
| 48 | MAPK11 | 0.68762837 |
| 49 | TAOK1 | 0.68381196 |
| 50 | IRAK1 | 0.63660807 |
| 51 | DYRK1B | 0.62912056 |
| 52 | MAP3K11 | 0.61133089 |
| 53 | JAK1 | 0.59939708 |
| 54 | MAP2K6 | 0.59836400 |
| 55 | PDK1 | 0.59167413 |
| 56 | PRKCA | 0.56937493 |
| 57 | PDGFRA | 0.55528938 |
| 58 | PRKCZ | 0.55253860 |
| 59 | YES1 | 0.50853020 |
| 60 | RET | 0.49028749 |
| 61 | * PRKACG | 0.48421984 |
| 62 | SRC | 0.46081943 |
| 63 | FYN | 0.44315815 |
| 64 | JAK2 | 0.42908438 |
| 65 | KSR2 | 0.42624165 |
| 66 | CAMK2D | 0.40783698 |
| 67 | CSK | 0.40757652 |
| 68 | ITK | 0.40435124 |
| 69 | TBK1 | 0.39755411 |
| 70 | PRKCD | 0.39550856 |
| 71 | PTK2 | 0.39036287 |
| 72 | CDK6 | 0.38514945 |
| 73 | BTK | 0.38325792 |
| 74 | PAK4 | 0.38273317 |
| 75 | CSF1R | 0.38086261 |
| 76 | MAP3K3 | 0.37444863 |
| 77 | IKBKE | 0.34689314 |
| 78 | TEC | 0.34219138 |
| 79 | MELK | 0.33792840 |
| 80 | CDK19 | 0.33714816 |
| 81 | MAP3K14 | 0.31525276 |
| 82 | SYK | 0.30845381 |
| 83 | NEK6 | 0.30805005 |
| 84 | ABL2 | 0.30782518 |
| 85 | CAMK2G | 0.30090172 |
| 86 | CAMK2B | 0.29088860 |
| 87 | GRK1 | 0.26135024 |
| 88 | PIK3CG | 0.26063189 |
| 89 | ZAP70 | 0.25127172 |
| 90 | JAK3 | 0.24330823 |
| 91 | BMX | 0.23588205 |
| 92 | MAPKAPK2 | 0.21901740 |
| 93 | LYN | 0.20091637 |
| 94 | LCK | 0.20050846 |
| 95 | IGF1R | 0.19227583 |
| 96 | KIT | 0.16506073 |
| 97 | IRAK4 | 0.15754731 |
| 98 | DAPK2 | 0.15704055 |
| 99 | MAP3K8 | 0.15452285 |
| 100 | RPS6KA2 | 0.15025041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Influenza A_Homo sapiens_hsa05164 | 8.61984188 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.26299063 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.73440443 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.42366874 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.42209529 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.80074315 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.66869113 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.52894356 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40174126 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.32956433 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29404467 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22088707 |
| 13 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.08201897 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.97576404 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93530530 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.92797105 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87228037 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86681204 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.86150020 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.79329424 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.76052396 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74744014 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69550212 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67267497 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.65955225 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.65059724 |
| 27 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.64872836 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45433415 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44998971 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39722544 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36422635 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36087193 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31727600 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25577130 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25261935 |
| 36 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.20416259 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11834512 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.09157326 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08563037 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02654676 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.02618167 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96179930 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94072565 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93266456 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 0.80850790 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74987215 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74840019 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71923689 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71440494 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71383976 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66859558 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63078506 |
| 53 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61483963 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58698380 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53408631 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53093274 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48613217 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.48539195 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47799278 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.43097925 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41611343 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38299126 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37013699 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.35342711 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35190843 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34547342 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34103521 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33623531 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32578614 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.32513967 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30512735 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30160182 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28712002 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24360328 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23831622 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.18856236 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18186675 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17359082 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.14332450 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.14266553 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.14098242 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12440905 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12127256 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.11224263 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.11149970 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10779277 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10726109 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.10107622 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.09663988 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09280146 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.08133482 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07114241 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06880901 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.06175895 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.05860963 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.05728642 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.01957002 |
| 98 | Gap junction_Homo sapiens_hsa04540 | 0.01351532 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01302040 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.00997230 |

